News & Updates

Molecular testing may be used to identify the origin of a basal cell carcinoma (BCC) metastasis, indicating its prognostic and therapeutic value, suggests a recent study.

People who had an allergic response to the first dose of COVID-19 vaccination or who believe they will have an allergy to vaccination should not let their worries delay getting vaccinated — as most of them can still be fully vaccinated safely, suggest studies presented at ACAAI 2021.

The application of ruxolitinib cream led to significant improvements in facial and total body repigmentation among adolescents and adults with vitiligo, according to two phase III studies presented at EADV 2021.